Vimian Group

26,62 SEK

+0,83 %

Mindre end 1K følgere

VIMIAN

NASDAQ Stockholm

Health Care Providers

Health Care

Oversigt

Finansielt overblik og estimater

Ejerskab

Investorkonsensus

+0,83 %

-11,27 %

-12,26 %

-8,65 %

-15,49 %

-32,95 %

-13,93 %

-

-66,02 %

Vimian Group is a group operating in animal health. The company, through its subsidiaries, delivers pharmaceuticals and technical solutions to veterinarians, laboratories and pet owners. The products include, for example, pharmaceuticals with associated clinical research and digital platforms for veterinary clinics. The company operates on a global level with headquarters in Stockholm.

Markedsværdi

14,09 mia. SEK

Aktieomsætning

3,73 mio. SEK

Omsætning

4,3 mia.

EBIT %

13,13 %

P/E

58,02

Udbytteafkast, %

-

Omsætning og EBIT-margin

Omsætning mia.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender

12.2

2026

Årsrapport '25

29.4

2026

Delårsrapport Q1'26

29.4

2026

Generalforsamling '26

Alle

Selskabspræsentationer

Selskabsmeddelelser

ViserAlle indholdstyper

Pressemeddelelse2.2.2026, 09.00

Invitation to Vimian’s year-end report for 2025

Vimian Group, Audiocast, Q4'25

Videopræsentation12.2.2026, 08.00

Vimian Group, Audiocast, Q4'25

Selskabsmeddelelse12.1.2026, 06.45

Vimian Group AB (publ) announces departure of Head of Specialty Pharma segment

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Selskabsmeddelelse30.12.2025, 16.30

Change in the number of shares and votes in Vimian

Pressemeddelelse23.12.2025, 07.05

Vimian acquires I-Vet to strengthen its companion animal diagnostics offering

Selskabsmeddelelse22.12.2025, 20.30

Vimian has resolved to issue and repurchase additional class D shares, class E1 2025 shares, class E2 2025 shares, and class E3 2025 shares as part of its long-term incentive program 2025

Selskabsmeddelelse28.11.2025, 16.30

Change in the number of shares and votes in Vimian

Selskabsmeddelelse24.11.2025, 06.15

Vimian Group AB (publ) appoints Alireza Tajbakhsh as CEO

Selskabsmeddelelse27.10.2025, 06.00

Vimian has resolved to issue and repurchase class D shares, class E1 2025 shares, class E2 2025 shares, and class E3 2025 shares as part of its long-term incentive program 2025

Vimian Group, Audiocast, Q3'25

Videopræsentation22.10.2025, 07.00

Vimian Group, Audiocast, Q3'25

Selskabsmeddelelse22.10.2025, 05.45

Vimian’s Interim Report for the third quarter of 2025

Pressemeddelelse13.10.2025, 08.00

Invitation to Vimian’s Interim Report for the third quarter of 2025

Selskabsmeddelelse23.9.2025, 08.00

Nomination Committee for Vimian’s 2026 Annual General Meeting

Selskabsmeddelelse29.8.2025, 23.03

Superior Court of Delaware awards Vimian USD 40.2 million in indemnification dispute

Selskabsmeddelelse31.7.2025, 15.30

Change in the number of shares and votes in Vimian

Vimian Group, Audiocast, Q2'25

Videopræsentation18.7.2025, 07.00

Vimian Group, Audiocast, Q2'25

Selskabsmeddelelse18.7.2025, 05.45

Vimian’s Interim Report for the second quarter of 2025

Selskabsmeddelelse17.7.2025, 16.30

Vimian Group AB (publ) CEO Patrik Eriksson steps down

Pressemeddelelse7.7.2025, 11.00

Invitation to Vimian’s Interim Report for the second quarter of 2025

Selskabsmeddelelse30.6.2025, 15.30

Change in the number of shares and votes in Vimian

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.